Upstream Bio, Inc.

ACTIVE

460 Totten Pond Rd Ste 420, Waltham, Massachusetts, United Stateswww.upstreambio.comHolding

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

70.0%

Phase 1

20.0%

Trial Status Distribution

Active, not recruiting

30.0%

Completed

40.0%

Not yet recruiting

10.0%

Recruiting

20.0%

Clinical Trials

Trials sponsored by this organization (10)

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Phase 2

Not yet recruiting

interventional

Feb 2026666 participants

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Phase 2

Active, not recruiting

interventional

Jul 2025666 participants

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

Phase 2

Active, not recruiting

interventional

May 2025396 participants

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants with Severe Asthma (VALIANT)

Active, not recruiting

interventional

Jun 202428 participants

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Phase 2

Completed

interventional

Feb 2024479 participants

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Phase 2

Completed

interventional

Dec 202381 participants

Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults

Phase 1

Completed

interventional

Dec 202232 participants

Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics

Phase 1

Completed

interventional

Jul 202232 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations